about
A cross sectional study of knowledge and attitudes towards tuberculosis amongst front-line tuberculosis personnel in high burden areas of Lima, PeruAcquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social DeterminantsAdaptation of a web-based, open source electronic medical record system platform to support a large study of tuberculosis epidemiologyIdentifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic DataChronic airflow obstruction after successful treatment of multidrug-resistant tuberculosisAge-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden settingRAPID HOME-BASED HIV TESTING TO REDUCE COSTS IN A LARGE TUBERCULOSIS COHORT STUDY.Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household ContactsPyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.Parasite infection and tuberculosis disease among children: a case-control study.The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts.Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.Tuberculosis and chronic respiratory disease: a systematic review.Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.Addressing tuberculosis patients' medical and socio-economic needs: a comprehensive programmatic approach.Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.Community-Based Accompaniment with Supervised Antiretrovirals for HIV-Positive Adults in Peru: A Cluster-Randomized Trial.Barriers to the diagnosis of childhood tuberculosis: a qualitative study.Cigarette smoking among tuberculosis patients increases risk of transmission to child contacts.Validation of 2 Spanish-Language Scales to Assess HIV-Related Stigma in Communities.Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.Development and Validation of a Food Frequency Questionnaire to Estimate Intake among Children and Adolescents in Urban Peru.An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.Mental disorders and drug/alcohol use in patients commencing extensively drug-resistant tuberculosis treatment.Genotyping Multi-Drug Resistant M. tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray.Vitamin E Status Is Inversely Associated with Risk of Incident Tuberculosis Disease among Household Contacts.Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.Protective effects of household-based TB interventions are robust to neighbourhood-level variation in exposure risk in Lima, Peru: a model-based analysis.Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.Automated TruTip nucleic acid extraction and purification from raw sputumCASITA: a controlled pilot study of community-based family coaching to stimulate early child development in Lima, PeruModifiable Factors Associated with Tuberculosis Disease in ChildrenFeasibility of the string test for tuberculosis diagnosis in children between 4 and 14 years oldReply to te Brake : Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
P50
Q28533646-F671BE9B-9A65-411D-897C-66D4C6413392Q28552456-44265614-A47F-4B93-AAF7-7CB035EA7427Q28710179-8AF2A3A2-2048-4236-B71F-7A8AA513A7E4Q30980449-006B9E95-93A7-46B6-B036-6F605FC3E22EQ33897501-882B27D7-12A8-4536-97BF-27FAC78FEC59Q34300539-715D9CAC-40E2-4141-BAA3-31DCC840A709Q34870784-4B6B0B1E-3882-41E1-ACDA-45661DC4DB40Q36115081-DF828102-AEAC-4F76-AF99-195315952D51Q36189923-CB335BBA-F7D2-4958-AC9B-9A3D55020CA5Q37358689-7A53657C-69DA-40AD-B0BE-456C9CCBC0ECQ37572935-6C991955-5CBF-4CC4-8EF7-B54A78E94151Q37604538-FBA999A3-8E49-4702-8835-836CB5C47453Q37669840-6EE79D5B-05B1-4909-AF97-5D199F0FBB04Q38391408-2B4966A0-06DE-42CC-90BE-1BE456D8F6B9Q38944222-46842322-54C8-4F3E-AA3E-081822CE8A7AQ39002021-5ED47681-EAD5-46F4-9795-709A97BC4DD2Q39560188-B0B4C969-A81F-4FC6-A4FC-6F9954E0CCA4Q40080354-99C6FB8B-2CED-45F4-9EDF-75E5C2AE8A16Q40091081-484162CA-2065-48F9-913E-1876F30742ACQ40191000-86EB71F2-E94A-4AB2-8B44-9D4184D9678FQ40192322-47DB3EFE-96C0-4589-8CE5-C59471F4A4B2Q40386466-6246B37D-F704-434D-B807-2E3F5B83F721Q40440057-9AEB6D3B-74B1-481D-B295-2671636E5AA2Q41708778-BCCA8CA5-2E29-4206-9DBA-834C853E646DQ41711520-1CD2B32C-7480-466D-A3BE-F86B9C7AAF5EQ42028836-42FCF787-1485-45E5-829C-EBFFD361D443Q42650259-1FC2DF23-29E5-42B6-93A2-AB00D35B22B7Q44398459-800482A4-1861-415C-8C7E-6641767E9230Q47100507-0AB8DA0F-3C42-4B71-86A6-FC51364A0F17Q47101115-6D0F2BBF-286E-4CBD-AE44-AD8D85F41829Q47203483-6355125C-A770-4EB2-9CF8-C38EE8F45280Q47552383-2C0BA2DA-C56D-445E-93DA-C42314F1B3D0Q47566309-02BC7EDD-D6DB-47B2-8E3A-379335A47C37Q47657566-4266A49E-785F-4DDB-AA33-BC51BBA76DB1Q47666276-C09AB6DB-7D94-429F-AFAC-1ED63A8FCB34Q56395664-0FA0D1CE-14D9-489B-B698-5B6A369D4DE2Q57923285-E59DA218-A008-4304-88F4-4F6BBD9339B6Q59273257-410DCA8D-D079-4F2B-ACD9-53F85B09B97FQ59340182-E4CD9733-D51D-4E83-9757-D2123DC7D615Q64072694-D1257161-CC70-4A78-90C3-5E03ADF2987A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Leonid Lecca
@ast
Leonid Lecca
@en
Leonid Lecca
@es
Leonid Lecca
@nl
type
label
Leonid Lecca
@ast
Leonid Lecca
@en
Leonid Lecca
@es
Leonid Lecca
@nl
prefLabel
Leonid Lecca
@ast
Leonid Lecca
@en
Leonid Lecca
@es
Leonid Lecca
@nl
P106
P31
P496
0000-0003-1363-3985